You may also like
Hematic Antegrade Repriming: A Reproducible Method to Decrease the Cardiopulmonary Bypass Insult
Here, we describe hematic antegrade repriming as an easy and reliable method that could be applied with any circuit in the market to decrease transfusion requirements, emboli, and inflammatory responses, reducing costs and the impact of CPB on postoperative recovery.
1 min read
A Retrospective Comparative Study of Minimally Invasive Extracorporeal Circulation Versus Conventional Extracorporeal Circulation in Emergency Coronary Artery Bypass Surgery Patients: A Single Surgeon Analysis
The purpose of this study was to compare the outcome of emergency coronary artery bypass grafting (CABG) operations using either minimally invasive extracorporeal circulation (MiECC) or conventional extracorporeal circulation (CECC) in patients requiring emergency CABG with regard to the perioperative course and the occurrence of major adverse cardiac and cerebral events (MACCE).
1 min read
ZymoGenetics Submits Citizen Petition to FDA Requesting Removal of Bovine Thrombin from Market in the Interest of Patient Safety
ZymoGenetics, Inc. (NASDAQ:ZGEN), announced today the submission of a Citizen Petition to the U.S. Food and Drug Administration (FDA) requesting that the FDA remove Thrombin-JMI® Thrombin, topical (bovine origin) from the market in the interest of patient safety. The Citizen Petition is prompted by recent reports of serious or fatal bleeding-related adverse events in surgical patients exposed to bovine (cattle-derived) thrombin.
3 min read